Provectus Biopharmaceuticals (PVCT) Stock Chart & Stock Price History $0.12 -0.01 (-7.26%) (As of 12/20/2024 05:55 PM ET) Add Compare Share Share Chart Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Provectus Biopharmaceuticals Stock Price Performance 5 Day Performance-8.94%1 Month Performance+5.54%3 Month Performance+33.33%6 Month Performance-23.44%Year-To-Date Performance+25.00%1 Year Performance+22.57% Receive PVCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Your chance to get on the next “60-Second Trade” (Ad)Ever heard of the “60-Second Trade”? It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days… In on Monday, out on Friday!Just head over here! PVCT Stock Chart for Saturday, December, 21, 2024 PVCT Chart by TradingView Provectus Biopharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/20/2024$0.13$0.12-7.26%$0.13$0.1296,909 shs$52.57 million12/19/2024$0.13$0.13-0.23%$0.13$0.12312,631 shs$56.69 million12/18/2024$0.13$0.13-0.92%$0.13$0.13128,447 shs$56.82 million12/17/2024$0.13$0.13-0.66%$0.13$0.13235,667 shs$57.35 million12/16/2024$0.13$0.13+2.95%$0.13$0.13210,638 shs$57.41 million12/13/2024$0.13$0.13-0.78%$0.13$0.1386,663 shs$53.80 million Get the Latest News and Ratings for PVCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/12/2024$0.13$0.13-0.77%$0.13$0.13367,429 shs$54.22 million12/11/2024$0.12$0.13+9.15%$0.13$0.13130,507 shs$54.64 million12/10/2024$0.14$0.12-14.93%$0.15$0.121.50 million shs$50.06 million12/09/2024$0.13$0.14+7.90%$0.14$0.13410,600 shs$58.84 million12/06/2024$0.13$0.13+1.09%$0.14$0.13587,865 shs$54.55 million12/05/2024$0.11$0.13+12.63%$0.13$0.11404,859 shs$53.96 million12/04/2024$0.12$0.11-5.86%$0.12$0.11570,620 shs$47.91 million12/03/2024$0.12$0.12+0.92%$0.12$0.11107,040 shs$50.90 million12/02/2024$0.12$0.12+1.69%$0.12$0.11347,964 shs$50.43 million11/29/2024$0.12$0.12-4.38%$0.12$0.1286,700 shs$49.59 million11/28/2024$0.12$0.12$0.12$0.12443,642 shs$51.86 million11/27/2024$0.12$0.12+7.16%$0.12$0.12443,642 shs$51.86 million11/26/2024$0.12$0.12-2.58%$0.12$0.11235,000 shs$48.40 million11/25/2024$0.12$0.12-1.42%$0.12$0.1265,130 shs$49.68 million11/22/2024$0.11$0.12+4.22%$0.12$0.11289,851 shs$49.80 million11/21/2024$0.11$0.11+3.27%$0.11$0.1172,285 shs$47.79 million11/20/2024$0.11$0.11+0.05%$0.11$0.11251,750 shs$46.27 million Related Companies TNYA Stock Price Chart FATE Stock Price Chart DMAC Stock Price Chart ATAI Stock Price Chart NLTX Stock Price Chart ZNTL Stock Price Chart ACRV Stock Price Chart MOLN Stock Price Chart ACRS Stock Price Chart BMEA Stock Price Chart Receive PVCT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Provectus Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:PVCT) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Provectus Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Provectus Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PVCT Stock Alerts